🇺🇸 FDA
Patent

US 9050285

Recombinant bacterium capable of eliciting an immune response against Streptococcus pneumoniae

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 9050285 (Recombinant bacterium capable of eliciting an immune response against Streptococcus pneumoniae) held by The United States of America National Institutes of Health (NH), U.S. Dept. of Health and Human Services (DHHS) expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America National Institutes of Health (NH), U.S. Dept. of Health and Human Services (DHHS)
Grant date
Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K39/092, A61P